findmyKOL
Clinical trialNCT04223765RecruitingPhase 1Interventional

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

SponsorUNC Lineberger Comprehensive Cancer CenterEnrollment20Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueFollicular LymphomaIndolent Non-hodgkin LymphomaMantle Cell LymphomaNodal Marginal Zone LymphomaSplenic Marginal Zone Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina

    Chapel Hill, North Carolina, United States

    Alicia PintoAnne Beaven, MDAshley ZanterBarbara SavoldoBenjamin VincentChristopher Dittus, MDEmily KassamGianpietro DottiGrace ParkJames CoghillJonathan Serody, MDKatarzyna JamiesonKimberly WehnerMarcie RichesNatalie Grover, MDPaul ArmisteadPaul EldridgeThomas Shea, MDWilliam Wood
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Nov 2020
Primary completion
22 Mar 2028
Completion
22 Mar 2043
Last update posted
20 Jan 2026
Registered enrollment
20
Registry id
NCT04223765
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.